Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study
Ohad Atia, Zivia Shavit-Brunschwig, Diane R. Mould, Ronen Stein, Manar Matar, Marina Aloi, Oren Ledder, Gili Focht, Darja Urlep, Jeffrey S. Hyams, Efrat Broide, Batia Weiss, Jeremiah Levine, Richard K. Russell, Dan Turner
Topics & Concepts
MedicineVedolizumabUlcerative colitisDosingCalprotectinInflammatory bowel diseaseFaecal calprotectinInternal medicineCohortProspective cohort studyAdverse effectCohort studyCrohn's diseasePediatricsDiseaseInflammatory Bowel DiseaseCeliac Disease Research and ManagementViral gastroenteritis research and epidemiology